The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Flagged first, then by citations
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 701–800 of 1,000
Correlating the Gut Microbiome to Health and Disease
Marques, T. M., Mall, J. G., Forsgård, R. A., Wall, R., Brummer, R. J., & de Vos, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00010-2 · Cited by 9
The Microbiome and Pediatric Transplantation
Elgarten, C. W., Margolis, E. B., & Kelly, M. S. (2023) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piad062 · Cited by 9
Reygner, J., Delannoy, J., Barba-Goudiaby, M.-T., Gasc, C., Levast, B., Gaschet, E., Ferraris, L., Paul, S., Kapel, N., Waligora‐Dupriet, A., et al. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.00016-24 · Cited by 11
The influence of microbiota on the efficacy and toxicity of immunotherapy in cancer treatment
Mahmoudian, F., Gheshlagh, S. R., Hemati, M., Farhadi, S., & Eslami, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10188-2 · Cited by 9
Jouhten, H., Ronkainen, A., Aakko, J., Salminen, S., Mattila, E. J., Arkkila, P., & Satokari, R. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01663 · Cited by 10
Sepsis and the Human Microbiome. Just Another Kind of Organ Failure? A Review
Tourelle, K. M., Boutin, S., Weigand, M. A., & Schmitt, F. C. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214831 · Cited by 10
The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment
Cariello, M., Gadaleta, R. M., & Moschetta, A. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000807 · Cited by 9
Advance in oral delivery of living material
Liu, H., Fan, Y., Zhong, J. P., Malkoch, M., Cai, Z., & Wang, Z. (2023) · Biomedical Technology · doi:10.1016/j.bmt.2022.12.003 · Cited by 9
Mohan, B. P., Loganathan, P., Khan, S. R., Garg, G., Muthusamy, A. K., Ponnada, S., Pasam, R. T., Chandan, S., & Tuteja, A. K. (2023) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01373-5 · Cited by 9
Stool banking for fecal microbiota transplantation: ready for prime time?
Saha, S., & Khanna, S. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-371 · Cited by 9
Prayag, P. S., Melinkeri, S. R., Patwardhan, S. A., Ajapuje, P. S., Gadhikar, H. P., Palnitkar, S., Simbasivam, R., Joshi, R., Baheti, A., Sheth, U. S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24607 · Cited by 8
The Impact of Diet on Clostridioides difficile Infection: A Review
Castro, M., Silver, H. J., Hazleton, K. Z., Lozupone, C., & Nicholson, M. R. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf233 · Cited by 8
Microbiome Therapeutics for Clostridioides difficile Infection
Lucky, C. W., Medernach, R. L., Kelly, B. J., Kwon, J. H., & Woodworth, M. H. (2025) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.07.007 · Cited by 8
Wang, L., Qiao, W., Zhen, X., Zhang, Y., & Dong, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1646897 · Cited by 8
Schlüter, J., Jogia, W., Matheis, F., Ebina, W., Sullivan, A. P., Gordon, K., de la Cruz, E. F., Victory-Hays, M. E., Heinly, M. J., Diefenbach, C., et al. (2025) · Infection and Immunity · doi:10.1128/iai.00390-25 · Cited by 8
Actualización sobre infección por Clostridium difficile en el paciente mayor
Boixareu, C. B., Tutor‐Ureta, P., & Ramos, A. (2020) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2019.12.003 · Cited by 8
Fecal Microbiota Transplantation Commonly Failed in Children With Co‐Morbidities
Kellermayer, R., Wu, Q., Nagy‐Szakal, D., Queliza, K., Ihekweazu, F. D., Bocchini, C. E., Magee, A. R., Oezguen, N., Spinler, J. K., Hollister, E. B., et al. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003336 · Cited by 8
Hu, M., Lian, W., Wang, F., Yang, C., Huang, W., Yang, J., Chen, I., & Yang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179689 · Cited by 8
Therapeutic alteration of the microbiota in rheumatic diseases: Hype or potential?
Stoll, M. L. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101806 · Cited by 8
McChalicher, C. W. J., Lombardo, M., Khanna, S., McKenzie, G. J., Halvorsen, E. M., Almomani, S., Schuster, B., Hasson, B. R., McGovern, B., Ege, D. S., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad298 · Cited by 8
Sun, Y., Song, J., Lan, X., Ma, F., Jiang, M., & Jiang, C. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s420689 · Cited by 8
Future Therapies of Hepatic Encephalopathy
Buckholz, A. P., & Brown, R. S. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.02.002 · Cited by 8
Hazra, R., Chattopadhyay, S., Mallick, A., Gayen, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02416-3 · Cited by 8
Kabage, A. J., Haselhorst, P. J., & Khoruts, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508950 · Cited by 8
Lam, A. Y., Gutin, L. S., Nguyen, Y., & Velayos, F. S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06521-x · Cited by 8
Mehta, S. R., & Yen, E. F. (2020) · Translational research · doi:10.1016/j.trsl.2020.11.013 · Cited by 8
The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies
Tourelle, K. M., Boutin, S., Weigand, M. A., & Schmitt, F. C. F. (2021) · Biomedicines · doi:10.3390/biomedicines9101305 · Cited by 11
Cryopreservation of stool samples altered the microbial viability quantitively and compositionally
Chen, A., Hu, Y., Zhang, Y., Li, Z., Zeng, Y., & Pang, X. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03169-1 · Cited by 8
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
Strahm, N., Didriksen, H., Fretheim, H., Molberg, Ø., Midtvedt, Ø., Farstad, I. N., Midtvedt, T., Lundin, K. E. A., Aabakken, L., Błyszczuk, P., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead014 · Cited by 8
Butters, C. T., Thursky, K., Hanna, D. T., Cole, T. S., Davidson, A. J., Buttery, J. P., & Haeusler, G. M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2171987 · Cited by 8
Intestinal microbiota in biliary diseases
Xia, Q., Liu, Q., & Ma, X. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000910 · Cited by 8
Encapsulation protocol for fecal microbiota transplantation
Sipos, D., Varga, A., Kappéter, Á., Halda-Kiss, B., Kása, P., Pál, S., Kocsis, B., & Péterfi, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1424376 · Cited by 8
Reproducible chemostat cultures to minimize eukaryotic viruses from fecal transplant material
Adamberg, S., Rasmussen, T. S., Larsen, S. B., Mao, X., Nielsen, D. S., & Adamberg, K. (2024) · iScience · doi:10.1016/j.isci.2024.110460 · Cited by 8
Giovanni, M. Y., Schneider, J. S., Calder, T., & Fauci, A. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa706 · Cited by 8
Seo, H., Chin, H. S., Kim, Y.-H., Moon, H. S., Kim, K., Nguyen, L. P., & Yong, D. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.4.424 · Cited by 8
Manzoor, S. E., Zaman, S., Whalley, C., Inglis, D., Bosworth, A., Kidd, M., Shabir, S., Quraishi, M. N., Green, C., Iqbal, T. H., et al. (2021) · F1000Research · doi:10.12688/f1000research.52178.1 · Cited by 8
The skin microbiome in dermatologic disease
MacGibeny, M. A., Adjei, S., Pyle, H. J., Bunick, C. G., Ghannoum, M. A., Grada, A. A., Harris-Tryon, T. A., Tyring, S. K., & Kong, H. H. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2024.07.1499 · Cited by 7
Skladaný, Ľ., Kubánek, N., Selčanová, S. A., Žilinčanová, D., Havaj, D. J., Sulejova, K. K., Šoltýs, K., Messingerová, L., Lichvár, M., Lafférs, L., et al. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00381-5 · Cited by 7
Microbial-Based Therapies to Restore and Rehabilitate Disrupted Coral Health
Dörr, M., Barno, A. R., Villela, H., García, F. C., Garcías-Bonet, N., Voolstra, C. R., & Peixoto, R. S. (2025) · Coral reefs of the world · doi:10.1007/978-3-031-76692-3_13 · Cited by 7
Yang, S., Pan, H., Wang, T., Zhou, X., Fan, L., Xiao, H., Zhou, Z., Xiao, Y., & Shi, D. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128136 · Cited by 7
Anti-interleukin-23 treatment linked to improved Clostridioides difficile infection survival
Madden, G. R., Preißner, R., Preißner, S., & Petri, W. A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2480195 · Cited by 7
LaPoint, P., Banks, K., Bacorn, M., Prasad, R., Romero-Soto, H. N., Namasivayam, S., Chen, Q., Patel, A., Levy, S., & Hourigan, S. K. (2025) · Microorganisms · doi:10.3390/microorganisms13061236 · Cited by 7
Wang, H., Tian, J., & Mi, J. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100415 · Cited by 7
Gut microbiome dysregulation in noninfectious uveitis
Liu, M., Geng, J., Liu, T., & Liu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1614304 · Cited by 7
Lucia, S. S. D., Nista, E. C., Candelli, M., Archilei, S., Deutschbein, F., Capuano, E., Gasbarrini, A., Franceschi, F., & Pignataro, G. (2025) · Cancers · doi:10.3390/cancers17223618 · Cited by 7
Rabbani, S. A., El‐Tanani, M., Janić, M., Janež, A., Tanani, Y., Hajeer, E., Matalka, M., Rizzo, M., & Sharma, R. K. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s540144 · Cited by 7
Jurgiel, J., Gromowski, T., Król, J. W., Bomba-Opon, D. A., Kościółek, T., & Wielgoś, M. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.09.001 · Cited by 7
Microbiome, GvHD, and immune reconstitution in allogeneic hematopoietic cell transplantation
Weber, D., Tariq, M., Hazenberg, M. D., Poeck, H., & Malard, F. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-02798-0 · Cited by 7
The Gut–Brain–Immune Axis in Glioma: Emerging Mechanisms and Therapeutic Opportunities
Feng, R., Yang, Z., Zhou, Y., & Zhao, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01680-3 · Cited by 7
Feng, C., He, Q., Kwok, L., & Sun, Z. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105818 · Cited by 7
Merli, P., Massa, M., Russo, A., Rea, F., CHIERICO, F. D., Galaverna, F., Bufalo, F. D., Pane, S., Algeri, M., Romeo, E. F., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01752-0 · Cited by 7
Zhang, M., Qin, X., Ding, B., Shen, Z., Sheng, Z.-K., Wu, S., Yang, Y., Xu, X., Hu, F., Wang, X., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11070953 · Cited by 7
Synthetic phage and its application in phage therapy
Kumar, A., & Yadav, A. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.03.009 · Cited by 7
What Is the Role of the Gut in Wound Infections?
Hyoju, S. K., Machutta, K., Krezalek, M. A., & Alverdy, J. C. (2023) · Advances in Surgery · doi:10.1016/j.yasu.2023.05.002 · Cited by 7
Gedgaudas, R., Bajaj, J. S., Skiecevičienė, J., Valantienė, I., Kiudeliene, E., Bang, C., Franke, A., Schreiber, S., & Kupčinskas, J. (2023) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4906 · Cited by 7
Douchant, K., He, S.-M., Noordhof, C., Greenlaw, J., Vancuren, S. J., Schroeter, K., Allen‐Vercoe, E., Sjaarda, C. P., Vanner, S. J., Petrof, E. O., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05778-6 · Cited by 7
Linnehan, B. K., Kodera, S. M., Allard, S. M., Brodie, E. C., Allaband, C., Knight, R. D., Lutz, H. L., Carroll, M. C., Meegan, J. M., Jensen, E. D., et al. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae026 · Cited by 7
Clostridioides difficile Infection in Kidney Transplant Recipients
Ding, U., Ooi, L., Wu, H. H. L., & Chinnadurai, R. (2024) · Pathogens · doi:10.3390/pathogens13020140 · Cited by 7
Ke, S., Villafuerte-Gálvez, J., Sun, Z., Cao, Y., Pollock, N. R., Chen, X., Kelly, C. P., & Liu, Y. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae470 · Cited by 7
Wu, X., Yang, J.-L., Bao, X., & Wang, Y.-J. (2024) · PeerJ · doi:10.7717/peerj.18185 · Cited by 7
Duo, H., Yang, Y., Zhang, G., Chen, Y., Cao, Y., Luo, L., Pan, H., & Ye, Q. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1430724 · Cited by 7
Self-citationLi, H., Guo, X., Liu, X., Zhao, J., Chen, W., & Yang, B. K. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105326 · Cited by 7
Expanding the β‐Lactamase Family in the Human Microbiome
Jia, B., Baek, J. H., Lee, J. K., Sun, Y., Kim, K. H., Jung, J. Y., & Jeon, C. O. (2024) · Advanced Science · doi:10.1002/advs.202403563 · Cited by 7
Modern approaches to the correction of the gut microbiota
Стуров, Н. В., Popov, S. V., & Zhukov, V. A. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-4-136-143 · Cited by 8
Fecal Microbiota and Human Intestinal Fluid Transplantation: Methodologies and Outlook
Chen, Y., Lin, Z., Jiaqu, C., Lv, X., Zhang, S., Ma, C., Yan, Y., Bo, Y., Di, Z., Hongliang, T., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.830004 · Cited by 7
Self-citationWang, M., Xie, X., Zhao, S., Han, W., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.990800 · Cited by 7
Interaction of microbiome and immunity in tumorigenesis and clinical treatment
Yu, Y., & Zhong, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113894 · Cited by 7
Feuerstadt, P., Oneto, C., Tillotson, G., & Hise, N. V. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s415681 · Cited by 7
Stefansson, M., Bladh, O., Flink, O., Skolling, O., Ekre, H.-P. T., Rombo, L., Engstrand, L. G., & Ursing, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292132 · Cited by 7
Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient
Porto, D. L., Mularoni, A., Castagnola, E., & Saffioti, C. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14159 · Cited by 7
Sehgal, K., Yadav, D., Saha, S., Mara, K. C., Grover, M., & Khanna, S. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.11.295 · Cited by 7
Agarwal, A., Maheshwari, A., Verma, S., Arrup, D., Phillips, L. E., Vinayek, R., Nair, P. P., Hagan, M., & Dutta, S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06459-0 · Cited by 7
Vandenhove, B., Canti, L., Schoemans, H. M., Beguin, Y. P., Baron, F., Graux, C., Kerre, T. C. C., & Servais, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583564 · Cited by 9
Limaye, M. A., & Ratner, A. J. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16174 · Cited by 7
Ronkainen, A., Khan, I., & Satokari, R. M. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.43 · Cited by 6
Hong, T., Wang, L., Ding, Y., Yi, L., Han, M., Gu, M., & Wu, J. (2025) · Cancer Science · doi:10.1111/cas.70201 · Cited by 6
de Groen, P., Blok, L. C. H. M., Snethlage, C. M. F., Hanssen, N. M. J., Rampanelli, E., & Nieuwdorp, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110788 · Cited by 6
Ichim, C., Boicean, A., Todor, S. B., Boeraș, I., Anderco, P., & Bîrluțiu, V. (2026) · Diagnostics · doi:10.3390/diagnostics16060846 · Cited by 6
Chen, Y., Wang, Y., Hu, J.-Y., Wang, E.-C., Jia, X.-H., Wang, J., Min, G., Jin, W.-L., & Jiang, L. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2652476 · Cited by 7
Self-citationBethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04442-2 · Cited by 6
Self-citationClostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician’s Dilemma
Conrad, M. A., & Kelsen, J. R. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab069 · Cited by 6
Hoelz, H., Heetmeyer, J., Tsakmaklis, A., Hiergeist, A., Siebert, K., Zen, F. D., Häcker, D., Metwaly, A., Neuhaus, K., Gessner, A., et al. (2023) · Nutrients · doi:10.3390/nu15071742 · Cited by 7
Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B
Xie, Y., Irwin, S. L., Estrada, A. C., Nelson, B., Bullock, A., Fontenot, L., Feng, H., Sun, M., & Koon, H. W. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae021 · Cited by 6
Escape Velocity—the Launch of Microbiome Therapies
Kelly, B. J., Kwon, J. H., & Woodworth, M. H. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae099 · Cited by 6
Chen, J., Song, Y. J., Zeng, W., Wang, L., Qin, J., Fang, L., & Ding, Y. (2024) · Shock · doi:10.1097/shk.0000000000002441 · Cited by 7
Impact of gut microbiota on cardiac aging
Yin, Z., Fu, L., Wang, Y., & Tai, S. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105639 · Cited by 6
The Microbiome and Pulmonary Immune Function
Baker, J. M., & Dickson, R. P. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.10.006 · Cited by 6
Wang, L., Teng, X., Wu, S., Zhao, C., & Haihui, H. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107468 · Cited by 6
Regulatory issues for genetically modified animals
Hackett, P. B. (2020) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2019307 · Cited by 6
Bestfater, C., Vehreschild, M. J. G. T., Stallmach, A., Tüffers, K., Erhardt, A., Frank, T., Glück, T., Goeser, F., Sellge, G., Solbach, P., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.02.022 · Cited by 6
Quantitative Structure–Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors
Bhuvaneswari, S., Velmurugan, B. A., Ramalakshmi, N., & Arun-Kumar, S. (2021) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-021-02513-x · Cited by 6
Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease
Wang, X., Zhao, J., Feng, Y., Feng, Z., Ye, Y., Liu, L., Kang, G., & Cao, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.916543 · Cited by 6
Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile
Pal, R., & Seleem, M. N. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01755-23 · Cited by 6
Factors of faecal microbiota transplantation applied to cancer management
Liu, Y.-H., Chen, J., Chen, X., & Liu, H. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2023.2299724 · Cited by 6
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop
Sherrill-Mix, S. A., Connors, K. A., Aldrovandi, G. M., Brenchley, J. M., Boucher, C. A., Bushman, F. D., Collman, R. G., Dandekar, S., Klatt, N. R., Lagenaur, L. A., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0121 · Cited by 6
Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis
Hatton, G. B., Ran, S., Tranah, T. H., & Shawcross, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00520-2 · Cited by 6
Long term management of ulcerative colitis with Faecal Microbiota Transplantation
Singh, A., Mahajan, R., Kao, D. H., Midha, V., & Sood, A. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100026 · Cited by 6
Faecal microbiota transplantation: more screening for old and new pathogens
Hohmann, E. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30850-1 · Cited by 6
Self-citationAlternative Diagnoses in Pediatric Fecal Microbiota Transplant Referral Patients
Ruan, W. H., & Kellermayer, R. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003060 · Cited by 6
Human Gut Microbiome: A Potential Prospective to Counter Antibiotic-Resistant Pathogens
Yadav, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00005-x · Cited by 6
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
